z-logo
open-access-imgOpen Access
A new paradigm for leprosy diagnosis based on host gene expression
Author(s) -
Thyago Leal-Calvo,
Charlotte Avanzi,
Mayara Abud Mendes,
Andrej Benjak,
Philippe Busso,
Roberta Olmo Pinheiro,
Euzenir Nunes Sarno,
Stewart T. Cole,
Milton Ozório Moraes
Publication year - 2021
Publication title -
plos pathogens
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.719
H-Index - 206
eISSN - 1553-7374
pISSN - 1553-7366
DOI - 10.1371/journal.ppat.1009972
Subject(s) - leprosy , transcriptome , biology , mycobacterium leprae , immune system , gene expression profiling , immunology , disease , skin biopsy , gene , gene expression , biopsy , medicine , pathology , genetics
Transcriptional profiling is a powerful tool to investigate and detect human diseases. In this study, we used bulk RNA-sequencing (RNA-Seq) to compare the transcriptomes in skin lesions of leprosy patients or controls affected by other dermal conditions such as granuloma annulare, a confounder for paucibacillary leprosy. We identified five genes capable of accurately distinguishing multibacillary and paucibacillary leprosy from other skin conditions. Indoleamine 2,3-dioxygenase 1 ( IDO1 ) expression alone was highly discriminatory, followed by TLR10 , BLK , CD38 , and SLAMF7 , whereas the HS3ST2 and CD40LG mRNA separated multi- and paucibacillary leprosy. Finally, from the main differentially expressed genes (DEG) and enriched pathways, we conclude that paucibacillary disease is characterized by epithelioid transformation and granuloma formation, with an exacerbated cellular immune response, while multibacillary leprosy features epithelial-mesenchymal transition with phagocytic and lipid biogenesis patterns in the skin. These findings will help catalyze the development of better diagnostic tools and potential host-based therapeutic interventions. Finally, our data may help elucidate host-pathogen interplay driving disease clinical manifestations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here